跳至主要内容
临床试验/NCT05955014
NCT05955014招募中不适用

Data Collection Protocol for Patients With Von Hippel Lindau Disease

M.D. Anderson Cancer Center2 个研究点 分布在 1 个国家目标入组 125 人开始时间: 2023年8月24日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
125
试验地点
2
主要终点
Progression-free survival (PFS)

研究概览

简要总结

To collect information from patients with vHL disease. Information collected will include data on the status of the disease, any surgeries or therapies patients have received for vHL disease, and quality of life.

详细描述

Primary Objectives:

  • Obtain prospective and retrospective data on lesion development, surgical history and systemic therapy use in patients with vHL disease
  • Assess genotype-phenotype correlation between VHL mutation type and patterns of lesion development
  • Assess genotype-phenotype correlation for response to belzutifan in an organ-specific manner

Secondary Objectives:

--Obtain quality of life data in patients with vHL disease

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Presence of genetic confirmation or clinical criteria consistent with vHL disease.
  • Ability to understand and the willingness to sign a written informed consent document.

排除标准

  • Patients with psychiatric illness/social situations that would limit compliance with study requirements.

结局指标

主要结局

Progression-free survival (PFS)

时间窗: through study completion; an average of 1 year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验